Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

E. Raskob, Gary; van Es, Nick; Verhamme, Peter; Carrier, Marc; Di Nisio, Marcello; García, David; Grosso, Michael; K. Kakkar, Ajay; J. Kovacs, Michael; Mercuri, Michele; Meyer, Guy; Segers, Annelise; Shi, Minggao; Wang, Tzu‐Fei; Yeo, Erik; Zhang, George; I. Zwicker, Jeffrey; I. Weitz, Jeffrey; R. Büller, Harry

doi:10.1056/nejmoa1711948

Public

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Published in New England Journal of Medicine • Dec 12, 2017

Authors:

Gary E. Raskob

Nick van Es

Peter Verhamme

Abstract

BACKGROUND: Low-molecular-weight heparin is the standard treatment for cancer-associated venous thromboembolism. The role of treatment with direct oral anticoagulant agents is unclear. METHODS: In this open-label, noninferiority trial, we randomly assigned patients with cancer who had acute symptoma...

Subject

Edoxaban

Venous thromboembolism

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!